Companies › SCYX
SCYNEXIS INC (SCYX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001178253 · EDGAR filings · Updated 2026-07-20
SCYNEXIS INC (SCYX) has reported institutional ownership of 66.8%, with 44 institutional managers holding positions valued at $27.3M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-20 — SCHEDULE 13G/A filed
- 2026-07-08 — SCHEDULE 13G/A filed
- 2026-06-30 — Insider transaction reported (Form 4)
- 2026-06-30 — Insider transaction reported (Form 4)
- 2026-06-30 — Insider transaction reported (Form 4)
- 2026-06-30 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SCYNEXIS INC has 44 institutional holders and institutional ownership of 66.8%.
Insider activity
Insiders reported 11 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
Elicio Therapeutics Inc (ELTX) · CANOPY GROWTH CORPORATION (CGC) · ACCURAY INC DEL (ARAY) · DOCGO INC (DCGO) · IMAGENEBIO INC (IMA) · STREAMEX (STEX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.